학술논문
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?
Document Type
Article
Author
Source
In: European Journal of Clinical Pharmacology . (European Journal of Clinical Pharmacology, June 2024, 80(6):847-853)
Subject
Language
English
ISSN
14321041
00316970
00316970